Similarly, MT-SLP-76 enhanced in vivo activity of CD19-4-1BBζ CAR in a model of CD19 ultra-low leukemia (600 molecules cell−1), whereas overexpression of either cytosolic SLP-76 or ZAP-70 had minimal effect (Extended Data Fig. 3d). This evidence concerns the gene CD19 and leukemia.